Momenta Pharmaceuticals
Why Robinhood?
You can watch MNTA and buy or sell other stocks, ETFs, and their options commission-free!About MNTA
Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection.
MNTA Key Statistics
Stock Snapshot
The current Momenta Pharmaceuticals(MNTA) stock price is $52.48, with a market capitalization of 6.24B. The stock trades at a price-to-earnings (P/E) ratio of -24.70.
On 2026-07-10, Momenta Pharmaceuticals(MNTA) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 2.68M.
Over the past 52 weeks, Momenta Pharmaceuticals(MNTA) stock has traded between a high of $52.53 and a low of $12.58.
Over the past 52 weeks, Momenta Pharmaceuticals(MNTA) stock has traded between a high of $52.53 and a low of $12.58.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.